4.5 Review

Optimising the management of pulmonary arterial hypertension patients: emergency treatments

期刊

EUROPEAN RESPIRATORY REVIEW
卷 19, 期 117, 页码 204-211

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09059180.00004910

关键词

Emergencies; organisation of care; pulmonary arterial hypertension

资金

  1. Actelion
  2. Encysive
  3. Pfizer
  4. GlaxoSmithKline

向作者/读者索取更多资源

Pulmonary arterial hypertension (PAH) is a rare and potentially fatal disease whose management is usually restricted to a few specialised centres. As patients do not necessarily live in the neighbourhood of these centres, daily care and emergencies have to be delegated to first and second lines. Treatment guidelines do not usually provide recommendations for acute emergency situations as evidence is scarce. This short review provides a description of our therapeutic protocols based on available data. A model of transmural organisation of care for PAH patients, currently applied in Belgium, is described. Thereafter, based on an analysis of the reasons of death in the PAH population, a review of the main emergencies is provided. Cardiac arrest and resuscitation, decompensated right heart failure, respiratory failure, arrhythmia, pericardial effusion, haemoptysis, surgery and drug-related adverse events will be discussed successively. Case reports showing the precariousness of PAH patients will enforce our thesis of the need for optimal patient management organisation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据